Browse by author
Lookup NU author(s): Dr Simon Tual-Chalot, Professor Kimon Stamatelopoulos, Dr Aikaterini GatsiouORCiD, Professor Konstantinos StellosORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2023 The AuthorsAtherosclerotic cardiovascular disease (ASCVD) remains the major cause of premature death and disability worldwide, even when patients with an established manifestation of atherosclerotic heart disease are optimally treated according to the clinical guidelines. Apart from the epigenetic control of transcription of the genetic information to messenger RNAs (mRNAs), gene expression is tightly controlled at the post-transcriptional level before the initiation of translation. Although mRNAs are traditionally perceived as the messenger molecules that bring genetic information from the nuclear DNA to the cytoplasmic ribosomes for protein synthesis, emerging evidence suggests that processes controlling RNA metabolism, driven by RNA-binding proteins (RBPs), affect cellular function in health and disease. Over the recent years, vascular endothelial cell, smooth muscle cell and immune cell RBPs have emerged as key co- or post-transcriptional regulators of several genes related to vascular inflammation and atherosclerosis. In this review, we provide an overview of cell-specific function of RNA-binding proteins involved in all stages of ASCVD and how this knowledge may be used for the development of novel precision medicine therapeutics.
Author(s): Sachse M, Tual-Chalot S, Ciliberti G, Amponsah-Offeh M, Stamatelopoulos K, Gatsiou A, Stellos K
Publication type: Review
Publication status: Published
Journal: Atherosclerosis
Year: 2023
Volume: 374
Pages: 55-73
Print publication date: 01/06/2023
Online publication date: 16/01/2023
Acceptance date: 12/01/2023
ISSN (print): 0021-9150
ISSN (electronic): 1879-1484
Publisher: Elsevier Ireland Ltd
URL: https://doi.org/10.1016/j.atherosclerosis.2023.01.008
DOI: 10.1016/j.atherosclerosis.2023.01.008
